EML4/ALK and Ras Inhibitors

被引：0
|
作者：
Edelman, Martin J. [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
CELL LUNG-CANCER; EML4-ALK; IDENTIFICATION;
D O I：
10.1097/01.JTO.0000391381.40050.5c
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S495 / S496
页数：2
相关论文
共 50 条
  • [1] Effective Use of ALK Inhibitors in EML4::ALK-Positive Lymphatic Malformations
    Apsel Winger, Beth
    Dowd, Christopher F.
    Shimano, Kristin A.
    Devine, W. Patrick
    Mathes, Erin
    Frieden, Ilona
    Schaefer, Carrie
    Kothari, Alok
    PEDIATRIC BLOOD & CANCER, 2024,
  • [2] EML4::ALK fusions in complex lymphatic malformations
    Winger, Beth Apsel
    Devine, Walter Patrick
    Hsiao, Edward C.
    Zapala, Matthew
    Van Ziffle, Jessica
    Gupta, Nalin
    Frieden, Ilona J.
    Shimano, Kristin A.
    PEDIATRIC BLOOD & CANCER, 2023, 70 (09)
  • [3] A Novel EML4-ALK Variant Exon 6 of EML4 Fused to Exon 19 of ALK
    Penzel, Roland
    Schirmacher, Peter
    Warth, Arne
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1198 - 1199
  • [4] Localised ALK-positive histiocytosis in lung with EML4::ALK fusion
    Zou, Long
    Lu, Tao
    Li, Mei
    Wang, Anqi
    Zhang, Zixin
    Pan, Boju
    Sun, Jian
    PATHOLOGY, 2024, 56 (04) : 604 - 606
  • [5] EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers
    Y Fukuyoshi
    H Inoue
    Y Kita
    T Utsunomiya
    T Ishida
    M Mori
    British Journal of Cancer, 2008, 98 : 1536 - 1539
  • [6] ALK/EML4 translocation in non-squamous NSCLC and their predictors
    Dias, Margarida
    Linhas, Rita
    Antunes, Ana
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [7] EPIDEMIOLOGIC PROFILE OF PATIENTS WITH ALK/EML4 MUTATION IN A PRIVATE CLINIC
    Simoes, Maria Fernanda
    Barone, Camila Pinto
    Mascarenhas, Eldsamira
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) : S184 - S184
  • [8] Tacklng the EML4/ALK Fusion Oncogenes in Murine Models.
    Hawes, J.
    Vilimas, T.
    Collins, K.
    Kozlov, S.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 : S44 - S44
  • [9] EML4-ALK: Update on ALK Inhibitors
    Bearz, Alessandra
    Bertoli, Elisa
    Stanzione, Brigida
    De Carlo, Elisa
    Del Conte, Alessandro
    Bortolot, Martina
    Torresan, Sara
    Berto, Eleonora
    Da Ros, Valentina
    Pelin, Giulia Maria
    Fassetta, Kelly
    Rossetto, Silvia
    Spina, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (01)
  • [10] Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
    J Tanizaki
    I Okamoto
    K Takezawa
    K Sakai
    K Azuma
    K Kuwata
    H Yamaguchi
    E Hatashita
    K Nishio
    P A Janne
    K Nakagawa
    British Journal of Cancer, 2012, 106 : 763 - 767
12345